{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:14:23Z","timestamp":1767892463623,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.clon.2022.01.042","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T08:03:44Z","timestamp":1645430624000},"page":"e298-e304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Treatment Outcomes of Low-grade Lymphoma of the Orbit"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3089-2006","authenticated-orcid":false,"given":"C.L.","family":"Holloway","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Pickles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5017-1834","authenticated-orcid":false,"given":"N.S.","family":"Croteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.S.","family":"Wai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2022.01.042_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1477-7819-11-73","article-title":"Orbital lymphoma: diagnostic approach and treatment outcome","volume":"11","author":"Eckardt","year":"2013","journal-title":"World J Surg Oncol"},{"issue":"3","key":"10.1016\/j.clon.2022.01.042_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood-2008-12-195453","article-title":"Extranodal marginal zone lymphoma of the ocular adnexa","volume":"114","author":"Stefanovic","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clon.2022.01.042_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1182\/blood-2018-04-843540","article-title":"Definitive radiotherapy for localized follicular lymphoma stage by 18F-FDG PET-CT: a collaborative study by ILROG","volume":"133","author":"Brady","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.clon.2022.01.042_bib4","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A\u00a0class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"10.1016\/j.clon.2022.01.042_bib5","series-title":"A\u00a0language and environment for statistical computing","year":"2019"},{"key":"10.1016\/j.clon.2022.01.042_bib6","series-title":"A\u00a0package for survival analysis in S. version 2.44","author":"Therneau","year":"2015"},{"key":"10.1016\/j.clon.2022.01.042_bib7","series-title":"Modeling survival data: extending the Cox model","author":"Therneau","year":"2000"},{"key":"10.1016\/j.clon.2022.01.042_bib8","series-title":"Subdistribution analysis of competing risks. R package version 2.2-10","author":"cmprsk","year":"2020"},{"key":"10.1016\/j.clon.2022.01.042_bib9","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/annonc\/mdn692","article-title":"Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma","volume":"20","author":"Esmaeli","year":"2009","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.clon.2022.01.042_bib10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3109\/10428194.2012.717279","article-title":"Efficacy of low dose radiotherapy for primary orbital marginal zone lymphoma","volume":"54","author":"Tran","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"16","key":"10.1016\/j.clon.2022.01.042_bib11","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/cncr.25226","article-title":"Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy","volume":"116","author":"Goda","year":"2010","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.clon.2022.01.042_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","article-title":"Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial","volume":"100","author":"Lowry","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2022.01.042_bib13","author":"National Comprehensive Cancer Network"},{"issue":"5","key":"10.1016\/j.clon.2022.01.042_bib14","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ijrobp.2013.04.035","article-title":"Low-dose radiation therapy (2 Gy \u00d7 2) in the treatment of orbital lymphoma","volume":"86","author":"Fasola","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.clon.2022.01.042_bib15","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/hed.24717","article-title":"Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma","volume":"39","author":"Pinnix","year":"2017","journal-title":"Head Neck"},{"key":"10.1016\/j.clon.2022.01.042_bib16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1470-2045(20)30686-0","article-title":"4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial","volume":"22","author":"Hoskin","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clon.2022.01.042_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","article-title":"Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"92","author":"Yahalom","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clon.2022.01.042_bib18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijrobp.2004.03.039","article-title":"Orbital lymphoma: is it necessary to treat the entire orbit?","volume":"60","author":"Pfeffer","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.clon.2022.01.042_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.prro.2015.11.013","article-title":"Partial orbit irradiation achieves excellent outcomes for primary orbital lymphoma","volume":"6","author":"Binkley","year":"2016","journal-title":"Pract Radiat Oncol"},{"issue":"6","key":"10.1016\/j.clon.2022.01.042_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/01676830.2019.1704032","article-title":"Epidemiology, outcomes and prognostic factors of orbital lymphoma in the United States","volume":"39","author":"Ahmed","year":"2020","journal-title":"Orbit"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093665552200070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093665552200070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:51:22Z","timestamp":1760543482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093665552200070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S093665552200070X"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2022.01.042","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment Outcomes of Low-grade Lymphoma of the Orbit","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2022.01.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}